Natural Products-based Drugs: Potential Drug Targets Against Neurological Degeneration

Curr Neuropharmacol. 2023;21(4):777-786. doi: 10.2174/1570159X21666230220102605.

Abstract

Phytochemicals or natural products have been studied extensively for their potential in the treatment of neurodegenerative diseases (NDs) like Parkinson's disease, Alzheimer's disease, etc. The neuronal structure loss and progressive dysfunction are the main characteristics of these diseases. In spite of impressive and thorough knowledge of neurodegenerative molecular pathways, little advancement has been found in the treatment of the same. Moreover, it was proved that natural products can be used efficiently in the treatment of NDs while certain issues regarding the patient's safety and clinical data are still existing. As ND is a bunch of diseases and it will start the myriad of pathological processes, active targeting of the molecular pathway behind ND will be the most efficient strategy to treat all ND-related diseases. The targeting pathway must prevent cell death and should restore the damaged neurons. In the treatment of ND and related diseases, natural products are playing the role of neuroprotective agents. This review will target the therapeutic potential of various phytochemicals which shows neuroprotective action.

Keywords: Alzheimer’s disease; Neurodegeneration; Parkinson’s disease; neuroprotective action; phytochemicals; targeting.

Publication types

  • Review

MeSH terms

  • Alzheimer Disease* / drug therapy
  • Biological Products* / pharmacology
  • Biological Products* / therapeutic use
  • Humans
  • Neuroprotective Agents* / chemistry
  • Neuroprotective Agents* / pharmacology
  • Neuroprotective Agents* / therapeutic use
  • Parkinson Disease* / drug therapy
  • Phytochemicals / chemistry
  • Phytochemicals / therapeutic use

Substances

  • Phytochemicals
  • Neuroprotective Agents
  • Biological Products